Miromatrix Medical Inc. (MIRO): Price and Financial Metrics
MIRO Price/Volume Stats
| Current price | $1.29 | 52-week high | $4.50 |
| Prev. close | $1.31 | 52-week low | $0.91 |
| Day low | $1.22 | Volume | 11,800 |
| Day high | $1.30 | Avg. volume | 44,689 |
| 50-day MA | $1.36 | Dividend yield | N/A |
| 200-day MA | $1.86 | Market Cap | 35.23M |
MIRO Stock Price Chart Interactive Chart >
MIRO Stock Summary
- MIROMATRIX MEDICAL INC's stock had its IPO on June 24, 2021, making it an older stock than only 5.88% of US equities in our set.
- With a price/sales ratio of 38.44, MIROMATRIX MEDICAL INC has a higher such ratio than 96.25% of stocks in our set.
- Revenue growth over the past 12 months for MIROMATRIX MEDICAL INC comes in at 3,261.18%, a number that bests 99.62% of the US stocks we're tracking.
- Stocks that are quantitatively similar to MIRO, based on their financial statements, market capitalization, and price volatility, are PSTV, ZYME, ADAP, PTN, and VCNX.
- Visit MIRO's SEC page to see the company's official filings. To visit the company's web site, go to www.miromatrix.com.
MIRO Valuation Summary
- MIRO's EV/EBIT ratio is -1.2; this is 110.34% lower than that of the median Healthcare stock.
- Over the past 27 months, MIRO's price/sales ratio has gone down 6409.1.
Below are key valuation metrics over time for MIRO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MIRO | 2023-09-22 | 38.5 | 1.7 | -1.3 | -1.2 |
| MIRO | 2023-09-21 | 39.0 | 1.7 | -1.3 | -1.2 |
| MIRO | 2023-09-20 | 38.5 | 1.7 | -1.3 | -1.2 |
| MIRO | 2023-09-19 | 39.8 | 1.8 | -1.3 | -1.3 |
| MIRO | 2023-09-18 | 38.7 | 1.7 | -1.3 | -1.2 |
| MIRO | 2023-09-15 | 38.7 | 1.7 | -1.3 | -1.2 |
MIRO Price Target
For more insight on analysts targets of MIRO, see our MIRO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $22.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Miromatrix Medical Inc. (MIRO) Company Bio
Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company also develops organ-derived biological products for various applications, such as soft tissue reinforcement and wound care. It uses its perfusion decellularization/recellularization technology to engineer transplantable organs for the people who need them. Miromatrix Medical Inc. has strategical partnerships with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. Miromatrix Medical Inc. was formerly known as TayTech, Inc. The company was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Latest MIRO News From Around the Web
Below are the latest news stories about MIROMATRIX MEDICAL INC that investors may wish to consider to help them evaluate MIRO as an investment opportunity.
Several Insiders Invested In Miromatrix Medical Flagging Positive NewsUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like... |
Miromatrix Announces Participation in H.C. Wainwright Global Investment ConferenceEDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the H.C. Wainwright Annual Global Investment Conference on September 11th, 2023. Miromatrix Medical’s management is scheduled to present at the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the |
Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics WorkshopEDEN PRAIRIE, Minn., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced its participation in the upcoming Alliance for Regenerative Medicine (ARM) Tissue Engineering and Therapeutics Workshop held on September 6, 2023. Miromatrix Medical is scheduled to present at the ARM Tissue and Engineering and Therapeutics Workshop f |
Miromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call TranscriptMiromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call Transcript August 19, 2023 Operator: Good day, and welcome to the Miromatrix Medical, Inc. Second Quarter 2023 Earnings Conference Call. All participants’ will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Max […] |
Q2 2023 Miromatrix Medical Inc Earnings CallQ2 2023 Miromatrix Medical Inc Earnings Call |
MIRO Price Returns
| 1-mo | -6.52% |
| 3-mo | -28.73% |
| 6-mo | -16.77% |
| 1-year | -70.62% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -56.86% |
| 2022 | -36.25% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...